Identification of genetic alterations related to chemoresistance in epithelial ovarian cancer

By Makhija S.   Sit A.   Edwards R.   Aufman K.   Weiss H.   Kanbour-Shakir A.   Gooding W.   D'Angelo G.   Ferrell R.   Raja S.   Godfrey T.E.  

Gynecologic Oncology, Vol. 90, Iss. 1, 2003-07 ,pp. : 3-9

Elsevier

Access to resources Recommend Favorite

Repression of Dicer is associated with invasive phenotype and chemoresistance in ovarian cancer

By            

Oncology Letters, Vol. 5, Iss. 4, 2013-01 ,pp. : 1149-1154

Spandidos Publications

Access to resources Recommend Favorite

Downregulation of BC200 in ovarian cancer contributes to cancer cell proliferation and chemoresistance to carboplatin

By Wu Di   Wang Tianzhen   Ren Chengcheng   Liu Lei   Kong Dan   Jin Xiaoming   Li Xiaobo   Zhang Guangmei  

Oncology Letters, Vol. 11, Iss. 2, 2016-02 ,pp. : 1189-1194

Spandidos Publications

Access to resources Recommend Favorite

Metformin targets Axl and Tyro3 receptor tyrosine kinases to inhibit cell proliferation and overcome chemoresistance in ovarian cancer cells

By Kim Nam-Yi   Lee Hwa-Young   Lee Chuhee  

International Journal of Oncology, Vol. 47, Iss. 1, 2015-07 ,pp. : 353-360

Spandidos Publications

Access to resources Recommend Favorite

Biomarker Conservation in Primary and Metastatic Epithelial Ovarian Cancer

By Tewari K.S.   Kyshtoobayeva A.S.   Mehta R.S.   Yu I.-R.   Burger R.A.   DiSaia P.J.   Fruehauf J.P.  

Gynecologic Oncology, Vol. 78, Iss. 2, 2000-08 ,pp. : 130-136

Elsevier

Access to resources Recommend Favorite